<p><strong>Hepatocellular Carcinoma</strong>: Sorafenib is indicated for the treatment of patients with unresectablehepatocellular carcinoma (HCC).<br />
<br />
<strong>Renal Cell Carcinoma</strong>: Sorafenib is indicated for the treatment of patients with advanced&nbsp;renal cell carcinoma&nbsp;(RCC).</p>